Assignee
ENVERIC BIOSCIENCES CANADA INC
CA·25 granted patents·11 pending applications·4 citations·filing 2022–2025
Top patents by PatentIndex Score
36 records- 0193US11707447B1C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jul 25, 2023·4 cites·13 claims
- 0286US12138276B2Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Granted Nov 12, 2024·0 cites·29 claims
- 0383US12128058B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Oct 29, 2024·0 cites·28 claims
- 0482US12133856B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Nov 5, 2024·0 cites·28 claims
- 0582US11945778B2C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Apr 2, 2024·0 cites·23 claims
- 0682US2025057861A1Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 0781US12378195B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Aug 5, 2025·0 cites·26 claims
- 0881US2025025483A1Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 0980US12077498B2C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Sep 3, 2024·0 cites·16 claims
- 1079US11918594B2Multi-substituent psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 5, 2024·0 cites·30 claims
- 1179US11845726B2C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Dec 19, 2023·0 cites·16 claims
- 1278US2025100967A1Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 1377US11998557B2Halogenated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jun 4, 2024·0 cites·22 claims
- 1476US12338231B1N-heterocycle substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2024·Granted Jun 24, 2025·0 cites·29 claims
- 1576US12065404B2C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Aug 20, 2024·0 cites·15 claims
- 1676US11746087B1C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Sep 5, 2023·0 cites·28 claims
- 1775US12492179B2Substituted ethylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Dec 9, 2025·0 cites·3 claims
- 1875US12358885B2Substituted n-propylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Jul 15, 2025·0 cites·12 claims
- 1975US12195439B1C1-substituted isopropylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Jan 14, 2025·0 cites·21 claims
- 2074US12187679B2Hydroxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 7, 2025·0 cites·26 claims
- 2174US11858895B2Aminated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Jan 2, 2024·0 cites·28 claims
- 2273US2026062399A1Substituted ethylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2025·Application pending·0 cites
- 2372US2025129036A1C1-substituted isopropylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2024·Application pending·0 cites
- 2470US12577232B2N-heterocycle substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2025·Granted Mar 17, 2026·0 cites·29 claims
- 2569US2025352513A2Salts of c4-carboxylic acid- and c4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Application pending·0 cites
- 2668US11891360B2Glycosylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Feb 6, 2024·0 cites·26 claims
- 2768US11891359B2Prenylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Feb 6, 2024·0 cites·12 claims
- 2868US11752130B2Carboxylated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Sep 12, 2023·0 cites·17 claims
- 2968US2025352512A2C4-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2023·Application pending·0 cites
- 3065US2026078102A1Substituted n-propylamine fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2025·Application pending·0 cites
- 3164US11845727B2Aldehyde and ketone derivatives of psilocybin and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Dec 19, 2023·0 cites·18 claims
- 3262US11931338B2Nitrilated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Granted Mar 19, 2024·0 cites·23 claims
- 3361US12428408B2Fused heterocyclic mescaline derivativesENVERIC BIOSCIENCES CANADA INC·Filed 2023·Granted Sep 30, 2025·0 cites·19 claims
- 3459US2023040398A1Nitrated psilocybin derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 3557US2025206701A1C4-carbonothioate-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
- 3655US2025197351A1C4-carboxylic acid-substituted tryptamine derivatives and methods of usingENVERIC BIOSCIENCES CANADA INC·Filed 2022·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when ENVERIC BIOSCIENCES CANADA INC files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Counts cover granted patents and pending applications in the PatentIndex corpus. How scoring works →